Panion & Bf Biotech Inc. (TPE:1760)

Panion & Bf Biotech Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	214.83	190.17	124.52	77.22	182.35	104.4
Depreciation & Amortization	136.37	138.42	164.42	170.39	163.55	143.62
Loss (Gain) From Sale of Assets	0.13	0.13	0.1	0.38	-6.28	0.44
Loss (Gain) From Sale of Investments	2.46	-0.24	-1.46	-7.5	93.68	-6.72
Loss (Gain) on Equity Investments	-0.89	-2.65	8.44	14.02	8.18	12.17
Stock-Based Compensation	-	-	-	-	-	11.72
Provision & Write-off of Bad Debts	1.73	0.85	-0.33	-1.05	0.08	2.09
Other Operating Activities	-13.51	-14.84	-16.02	-27.98	44.15	8.81
Change in Accounts Receivable	-23.95	1.08	4.72	1.31	-9.7	23.61
Change in Inventory	-21.55	-41.95	12.62	7.12	-15.88	32.33
Change in Accounts Payable	6.34	9.27	19.8	8.21	-5.69	-31.94
Change in Other Net Operating Assets	38.7	29.34	34.37	-64.69	65.4	69.98
Operating Cash Flow	340.64	309.57	351.19	177.42	489.87	401.23
Operating Cash Flow Growth	13.61%	-11.85%	97.94%	-63.78%	22.09%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-144.22	-148.34	-185.69	-181.23	-198.64	-170.01
Sale of Property, Plant & Equipment	-	-	0.11	0.01	24.72	-
Sale (Purchase) of Intangibles	-10	-10	-	-	-	-
Investment in Securities	-	27.87	13.19	15.05	15	-43.01
Other Investing Activities	2.77	1.29	13.62	10.9	14.46	-2.03
Investing Cash Flow	-151.45	-129.18	-158.77	-155.27	-144.47	-215.05

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	920	1,205	1,305	1,705	1,931
Long-Term Debt Issued	-	35	59.24	117.86	22.9	54.38
Total Debt Issued	1,205	955	1,264	1,423	1,728	1,985
Short-Term Debt Repaid	-	-1,000	-1,240	-1,165	-1,575	-2,131
Long-Term Debt Repaid	-	-63.29	-45.41	-31.12	-181.61	-634.13
Total Debt Repaid	-1,279	-1,063	-1,285	-1,196	-1,757	-2,765
Net Debt Issued (Repaid)	-74.3	-108.29	-21.17	226.74	-28.71	-779.75
Issuance of Common Stock	-	-	-	-	-	628.43
Common Dividends Paid	-154.33	-154.33	-128.61	-171.48	-128.61	-53.72
Other Financing Activities	-14.24	-15.29	-20.73	-6.6	-10.07	-12.72
Financing Cash Flow	-242.87	-277.9	-170.51	48.67	-167.39	-217.76

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	2.87	-0.54	1.84	-0.44	7.14	0.58
Net Cash Flow	-50.81	-98.06	23.75	70.37	185.15	-31.01

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	196.43	161.23	165.49	-3.81	291.23	231.22
Free Cash Flow Growth	29.66%	-2.57%	-	-	25.95%	-
Free Cash Flow Margin	9.31%	7.81%	8.15%	-0.20%	12.14%	12.16%
Free Cash Flow Per Share	2.29	1.88	1.93	-0.04	3.39	2.92
Levered Free Cash Flow	157.19	153.1	93.15	46.79	300.67	187.8
Unlevered Free Cash Flow	165.95	162.07	102.54	53.89	305.41	196.97

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	15.05	15.05	14.61	11.08	7.64	14.7
Cash Income Tax Paid	128.76	128.76	122.64	119.05	109.11	76.91
Change in Working Capital	-0.46	-2.27	71.51	-48.06	4.17	124.7

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error